A pulsational distance to Omega Centauri based on Near-Infrared Period-Luminosity relations of RR Lyrae stars

We present new Near-Infrared (J,K) magnitudes for 114 RR Lyrae stars in the globular cluster Omega Cen (NGC 5139) which we combine with data from the literature to construct a sample of 180 RR Lyrae stars with J and K mean magnitudes on a common photometric system. This is presently the largest such sample in any stellar system. We also present updated predictions for J,K-band Period-Luminosity relations for both fundamental and first-overtone RR Lyrae stars, based on synthetic horizontal branch models with metal abundance ranging from Z=0.0001 to Z=0.004. By adopting for the Omega Cen variables with measured metal abundances an alpha-element enhancement of a factor of 3 (about 0.5 dex) with respect to iron we find a true distance modulus of 13.70 (with a random error of 0.06 and a systematic error of 0.06), corresponding to a distance d=5.5 Kpc (with both random and systematic errors equal to 0.03 Kpc). Our estimate is in excellent agreement with the distance inferred for the eclipsing binary OGLEGC-17, but differ significantly from the recent distance estimates based on cluster dynamics and on high amplitude Delta Scuti stars.Comment: 24 pages, 7 figures, accepted for publication on The Astrophysical Journa

Synthetic properties of bright metal-poor variables. II. BL Her stars

We investigate the properties of the so-called BL Her stars, i.e., Population II Cepheids with periods shorter than 8 days, using updated pulsation models and evolutionary tracks computed adopting a metal abundance in the range of Z=0.0001 to Z=0.004. We derive the predicted Period-Magnitude (PM) and Period-Wesenheit (PW) relations at the various photometric bands and we show that the slopes of these relations are in good agreement with the slopes determined by observed variables in Galactic globular clusters, independently of the adopted M_V(RR)-[Fe/H] relation to get the cluster RR Lyrae-based distance. Moreover, we show that also the distances provided by the predicted PM and PW relations for BL Her stars agree within the errors with the RR Lyrae based values. The use of the predicted relations with W Vir stars, which are Population II Cepheids with periods longer than 8 days, provides no clear evidence for or against a change in the PM and PW slopes around P~10 days.Comment: 12 pages, 6 figures, 6 tables, accepted for publication in A&A on date 16/05/200

When Viruses Meet Fungi: Tackling the Enemies in Hematology

The association of invasive fungal infections (IFI) and viral infections has been described in patients with hematologic malignancies (HM), in particular in hematopoietic stem cell transplant recipients. Regrettably, the diagnosis is often challenging, making the treatment inappropriate in some circumstances. The present review takes into consideration the viral infections commonly associated with IFI. Clinical presentation of IFI and viral infections, risk factors, and impact on the outcome of HM patients are discussed throughout the paper

Immunotherapy as a turning point in the treatment of acute myeloid leukemia

Acute myeloid leukemia (AML) is a malignant disease of hematopoietic precursors at the earliest stage of maturation, resulting in a clonalproliferation of myoblasts replacing normal hematopoiesis. AML represents one of the most common types of leukemia, mostly affecting elderly patients. To date, standard chemotherapy protocols are only effective in patients at low risk of relapse and therapy-related mortality. The average 5-year overall survival (OS) is approximately 28%. Allogeneic hematopoietic stem cell transplantation (HSCT) improves prognosis but is limited by donor availability, a relatively young age of patients, and absence of significant comorbidities. Moreover, it is associated with significant morbidity and mortality. However, increasing understanding of AML immunobiology is leading to the development of innovative therapeutic strategies. Immunotherapy is considered an attractive strategy for controlling and eliminating the disease. It can be a real breakthrough in the treatment of leukemia, especially in patients who are not eligible forintensive chemotherapy. In this review, we focused on the progress of immunotherapy in the field of AML by discussing monoclonal antibodies (mAbs), immune checkpoint inhibitors, chimeric antigen receptor T cells (CAR-T cells), and vaccine therapeutic choices

Thickness-dependent crystallization on thermal anneal for titania/silica nm-layer composites deposited by ion beam sputter method.

Crystallization following thermal annealing of thin film stacks consisting of alternating nm-thick titania/silica layers was investigated. Several prototypes were designed, featuring a different number of titania/silica layer pairs, and different thicknesses (in the range from 4 to 40 nm, for the titania layers), but the same nominal refractive index (2.09) and optical thickness (a quarter of wavelength at 1064 nm). The prototypes were deposited by ion beam sputtering on silicon substrates. All prototypes were found to be amorphous as-deposited. Thermal annealing in air at progressive temperatures was subsequently performed. It was found that the titania layers eventually crystallized forming the anatase phase, while the silica layers remained always amorphous. However, progressively thinner layers exhibited progressively higher threshold temperatures for crystallization onset. Accordingly it can be expected that composites with thinner layers will be able to sustain higher annealing temperatures without crystallizing, and likely yielding better optical and mechanical properties for advanced coatings application. These results open the way to the use of materials like titania and hafnia, that crystallize easily under thermal anneal, but ARE otherwise promising candidate materials for HR coatings necessary for cryogenic 3rd generation laser interferometric gravitational wave detectors

CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias

Different transformation mechanisms have been proposed for elderly acute myeloid leukaemia (AML) and secondary AML (sAML) when compared with de novo AML or AML of younger patients. However, little is known regarding differences in the immunophenotypic profile of blast cells in these diseases. We systematically analysed, by flow cytometry, 148 patients affected by de novo (100 cases) or sAML (48 cases). By defining a cut-off level of 20% of CD34+ cells co-expressing CD90, the frequency of CD90+ cases was higher in sAML (40%) versus de novo AML (6%, P < 0.001), elderly AML (>60 years) (24%) versus AML of younger patients (10%, P = 0.010) and poor- versus good-risk karyotypes (according to the Medical Research Council classification, P < 0.001). The correlation between CD90 expression, sAML and unfavourable karyotypes was confirmed by analysing the subset of CD34+ AML cases alone (91/148). Consistently, univariate analysis showed that expression of CD90 was statistically relevant in predicting a shorter survival in CD90+ AML patients (P = 0.042). Our results, demonstrating CD90 expression in AML with unfavourable clinical and biological features, suggest an origin of these diseases from a CD90-expressing haemopoietic progenitor and indicate the use of CD90 as an additional marker of prognostic value in AML

B, V, I photometry of the complete sample of 23 Cepheids in the field of NGC 1866

We present the result of BVI photometry, obtained by using FORS@VLT, of the Cepheids present in the field of the Large Magellanic Cloud cluster NGC 1866. We found the 22 known variables plus an additional new Cepheid located about 10' from the cluster center. The accuracy of the photometry allowed us to derive B, V and I mean magnitudes with an uncertainty lower than 0.02 mag for 22 out of the 23 objects, with the exception of only one Cepheid (WS9) which presents a noisy light curve due to the probable occurrence of image blending. As a result, we provide accurate observational data for a substantial sample of variables all lying at the same distance and with a common original composition. The resulting period-luminosity relations are presented and briefly discussed.Comment: 4 pages, 6 figure, to appear in the proceedings of the Workshop "Stellar pulsation and evolution", 2005. Monte Porzio Catone, Italy. Eds.: A. R. Walker and G. Bon

Treatment of Acute Myeloid Leukemia with 20-30% Bone Marrow Blasts

The transition of patients with ≥20% <30% bone marrow (BM) blast from the FAB category of myelodysplasia to the family of acute myeloid leukemia (AML) according to the recent WHO classification has not resolved the argument as to whether the natural history and responsiveness to therapy of these diseases is comparable to that of AML with > 30% BM blast. These controversies are even more manifest when it comes to elderly patients in whom concern for intensive chemotherapy (IC) related toxicity is the critical determinant for the therapeutic choice. In fact, due to concerns of treatment-related morbidity and mortality associated with delivery of IC, approximately only 30% of all patients ≥65 years are considered eligible for this approach. Therefore, a great deal of attention has been dedicated to alternative agents such as hypomethylators (azacitidine and decitabine). Actually, these agents have shown efficacy with reduced toxicity when administered to elderly patients with 20–30% BM blasts and not eligible for IC. In the present review, we will discuss the clinical results achieved in the treatment of elderly patients with 20%–30% BM blasts AML using intensive chemotherapy (IC) or hypomethylating agents. Overall, our survey of the literature suggests that only controlled, randomized, clinical trials will answer the question as to whether hypomethylating agents has the potential to substitute for IC even in elderly patients with an optimal functional status